Analysts Set Smith & Nephew plc (LON:SN) Target Price at GBX 1,346.20

Shares of Smith & Nephew plc (LON:SN) have been assigned a consensus recommendation of “Moderate Buy” from the six analysts that are presently covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 12-month price objective among brokerages that have issued a report on the stock in the last year is GBX 1,346.20 ($16.91).

SN has been the topic of several research reports. Royal Bank of Canada reissued an “outperform” rating and set a GBX 1,500 ($18.84) price target on shares of Smith & Nephew in a research note on Tuesday. Barclays restated an “equal weight” rating and set a GBX 1,150 ($14.45) target price on shares of Smith & Nephew in a report on Friday, February 9th. Jefferies Financial Group reaffirmed a “buy” rating and issued a GBX 1,250 ($15.70) price target on shares of Smith & Nephew in a research note on Friday, May 3rd. Berenberg Bank reissued a “buy” rating and set a GBX 1,450 ($18.22) price objective on shares of Smith & Nephew in a research note on Thursday, May 2nd. Finally, JPMorgan Chase & Co. lifted their target price on shares of Smith & Nephew from GBX 1,300 ($16.33) to GBX 1,381 ($17.35) and gave the stock an “overweight” rating in a research note on Thursday, May 2nd.

Smith & Nephew Price Performance

SN opened at GBX 1,001.50 ($12.58) on Friday. The stock has a market capitalization of £8.76 billion, a P/E ratio of 4,172.92, a PEG ratio of 0.46 and a beta of 0.51. The company has a current ratio of 1.77, a quick ratio of 0.84 and a debt-to-equity ratio of 59.11. Smith & Nephew has a 12-month low of GBX 887 ($11.14) and a 12-month high of GBX 1,316.75 ($16.54). The stock has a 50-day moving average price of GBX 1,009.89 and a 200-day moving average price of GBX 1,036.23.

Smith & Nephew Increases Dividend

The firm also recently announced a dividend, which will be paid on Wednesday, May 22nd. Investors of record on Thursday, March 28th will be issued a dividend of $0.23 per share. This represents a dividend yield of 1.62%. The ex-dividend date is Thursday, March 28th. This is an increase from Smith & Nephew’s previous dividend of $0.14. Smith & Nephew’s dividend payout ratio is currently 12,500.00%.

Smith & Nephew Company Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.